The Emperor’s New Gepants: Are the Effects of the New Oral CGRP Antagonists Clinically Meaningful?
Author:
Affiliation:
1. Danish Headache Center; University Hospital, Rigshospitalet-Glostrup Hospital; Glostrup Denmark
2. Division of Headache, Department of Neurology; Brigham and Women’s Hospital, Harvard Medical School; Boston MA USA
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/head.13444/fullpdf
Reference23 articles.
1. Hans Christian Andersen The Emperor’s New Clothes https://www.andersen.sdu.dk/vaerk/hersholt/TheEmperorsNewClothes_e.html
2. Monoclonal antibodies for migraine prevention: Progress, but not a panacea;Loder;JAMA,2018
3. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan: A randomized, placebo-controlled, parallel-treatment trial;Ho;Lancet,2008
4. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine;Durham;CNS Drugs,2010
5. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention;Ho;Neurology,2014
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emicrania;EMC - Neurologia;2024-02
2. Treating acute migraine with ubrogepant;JAAPA;2023-09
3. The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development;Frontiers in Molecular Neuroscience;2023-06-29
4. Clinical efficacy and safety of rimegepant in the treatment of migraine: a meta-analysis of randomized controlled trials;Frontiers in Neurology;2023-06-20
5. Second-generation gepants in the treatment of migraine – a review of the findings of randomised controlled trials;Aktualności Neurologiczne;2023-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3